New Treatment Options for Acute Myeloid Leukemia in 2019

Marco Cerrano1,2, Raphael Itzykson3,4,5

  • 1Department of Hematology, Hopital Saint-Louis, Assistance Publique Hopitaux de Paris, Paris Diderot University, Paris, France.

Current Oncology Reports
|February 5, 2019
PubMed
Abstract

Insights

New targeted therapies are transforming acute myeloid leukemia (AML) treatment. Approved drugs and promising agents, including FLT3 and IDH inhibitors, offer new hope for AML patients.

Area of Science:

  • Hematology
  • Oncology
  • Genomics

Background:

  • Acute myeloid leukemia (AML) genomic characterization has identified numerous therapeutic targets.
  • Recent advancements have led to the approval of novel targeted therapies for AML.

Purpose of the Study:

  • To review data supporting new targeted therapies in AML.
  • To discuss promising drugs currently in development for AML.

Main Methods:

  • Review of clinical trial data and published literature.
  • Analysis of recent drug approvals and ongoing clinical investigations.

Main Results:

  • New formulations of cytotoxic agents (CPX-351, gemtuzumab ozogamicin) improve outcomes in specific AML subgroups.
  • Midostaurin is approved for FLT3-mutated AML when added to chemotherapy.
  • Selective FLT3 inhibitors and IDH inhibitors (enasidenib, ivosidenib) show efficacy in relapsed AML.
  • BCL2 inhibitor venetoclax combined with hypomethylating agents shows promising results.

Conclusions:

  • The AML therapeutic landscape now includes novel cytotoxic drugs, oncogene-targeted agents, and drugs targeting leukemic vulnerabilities.
  • Further research is needed to optimize the integration of these new therapies into AML management, including allogeneic stem cell transplantation.

Related Concept Videos

SI Units: 2019 Redefinition01:13

SI Units: 2019 Redefinition

Measurement is an indispensable part of analytical chemistry. The result of measurement helps quantify a substance's physical property and compare it with the physical property of another substance. Each measurement comprises two components - a number indicating the magnitude and a unit of measurement as a standard for comparison. Further, the same quantity can be measured using different units of measurement, which leads to differences in magnitude.
A standard set of units has been defined...
3.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.0K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.2K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
986
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K